Amiloidózis: vizsgálatok itt: Olaszország
18 of 37 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleTRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Where
- Ancona, Bologna, Brescia, Florence, Forli', Lecce, Milan, Naples, Padova, Pavia, Pisa, Rimini, Rome, Turin
- Életkor
- 18 év to 85 év
- People
- 2250 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07052903 · EU 2024-519917-72-00 - 4. fázisTaking peopleA Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to Acoramidis
- Where
- Bergamo, Bologna, Florence, Lecce, Milan, Naples, Padova, Pavia, Pisa, Siena
- Életkor
- 18 év to 90 év
- People
- 50 worldwide
- Run by
- Bayer
See details and how to joinNCT07298044 · EU 2025-521831-35-00 - 3. fázisTaking peopleMAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Where
- Bologna, Ferrara, Florence, Genoa, Pavia, Pisa, Rome, Trieste
- Életkor
- 18 év to 90 év
- People
- 1200 worldwide
- Run by
- Intellia Therapeutics
See details and how to joinNCT06128629 · EU 2023-507220-23-00 - 2. fázisNot yet taking people in OlaszországA Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
- Where
- Naples, Pavia, Pisa
- Életkor
- 18 év to 64 év
- People
- 60 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07224672 · EU 2025-522803-60-00 - 3. fázisCsak meghívásosA Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Where
- Bologna, Florence, Pavia
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT06679946 - 3. fázisTaking peopleCLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
- Where
- Ancona - Torrette, Bologna, Bolzano, Brescia, Cona, Florence, Ivrea, Lecco, Messina, Milan, Naples, Orbassano, Palermo, Pavia, Perugia, Pisa, Roma, Rome, San Donato Milanese, Trieste
- Életkor
- 18 év and over
- People
- 1280 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07207811 - No phaseTaking peopleEdge-to-edge Mitral Valve Repair in ATTR-CM
- Where
- Bergamo, Brescia
- Életkor
- 18 év and over
- People
- 106 worldwide
- Run by
- Medical University of Vienna
See details and how to joinNCT06075823 - 3. fázisFut, nem toborozTRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
- Where
- Florence, Messina, Milan, Padova, Pavia, Rome
- Életkor
- 18 év to 85 év
- People
- 125 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07223203 · EU 2025-522544-40-00 - 3. fázisNot yet taking people in OlaszországAn Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy
- Where
- Bologna, Ferrara, Florence, Forlì, Messina, Milan, Naples, Padova, Pavia, Pisa, Rome, Torino, Trieste
- People
- 1180 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07789483 · EU 2026-526755-57-00 - 1/2. fázisNot yet taking people in OlaszországA Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
- Where
- Genoa, Naples, Pavia, Reggio Emilia
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06292780 · EU 2023-507809-34-00 - 3. fázisNot yet taking people in OlaszországTo Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)
- Where
- Bologna, Florence, Messina, Pavia, Pisa, Rome
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- Eidos Therapeutics, a BridgeBio company
See details and how to joinNCT07116473 · EU 2024-513676-18-00 - 3. fázisTaking peopleAcoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Where
- Bologna, Florence, Messina, Pavia, Pisa, Rome
- Életkor
- 18 év to 75 év
- People
- 587 worldwide
- Run by
- Eidos Therapeutics, a BridgeBio company
See details and how to joinNCT06563895 · EU 2024-513547-82-00 - 1/2. fázisFut, nem toborozA Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
- Where
- Bologna, Pavia
- Életkor
- 18 év and over
- People
- 76 worldwide
- Run by
- AbbVie
See details and how to joinNCT06158854 · EU 2023-503429-20-00 - 3. fázisCsak meghívásosAn Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
- Where
- Ancona, Florence, Padova, Pavia, Pisa, Roma
- Életkor
- 18 év and over
- People
- 1400 worldwide
- Run by
- Ionis Pharmaceuticals, Inc.
See details and how to joinNCT05667493 - 4. fázisNot yet taking people in OlaszországHeArt Rate and quality of Life in transthyrEtin cardiac amYloidosis (HARLEY)
- Where
- Firenze, Genova, Roma
- Életkor
- 18 év and over
- People
- 104
- Run by
- Universita' Degli Studi Di Genova
See details and how to join2024-519107-10-00 - No phaseTaking peopleAn Interventional Pilot Study to Investigate the Feasibility and Acceptance of a Structured Psychological Support Program for Patients, Caregivers, and Presymptomatic Carriers in Hereditary Transthyretin Amyloidosis With Cardiomyopathy
- Where
- Pavia
- Életkor
- 18 év and over
- People
- 150
- Run by
- Fondazione IRCCS Policlinico San Matteo di Pavia
See details and how to joinNCT06907186 - 3. fázisTaking peopleA multi-center phase 3 study of 18F-florbetaben positron emission tomography/computed tomography (PET-CT) to non-invasively diagnose cardiac AL amyloidosis: the PETAL study.
- Where
- Bergamo, Ferrara, Naples, Pavia, Pisa, Trieste
- Életkor
- 18 év and over
- People
- 150
- Run by
- Fondazione Toscana Gabriele Monasterio
See details and how to join2024-517942-33-03 - 2. fázisTaking peopleEffect of dapagliflozin on the quality of life and exercise capacity of patients with amyloid transthyretin cardiac amyloidosis: a pilot, phase 2b study
- Where
- Pisa
- Életkor
- 18 év and over
- People
- 50
- Run by
- Fondazione Toscana Gabriele Monasterio
See details and how to join2023-504041-31-00